$INFY

Hindustan Times Reports India’s Benchmarks Open Lower as Oil Eases

India's Sensex and Nifty 50 opened lower on Oct. 26 as oil prices eased. Brent crude fell 1.82% to $114.60. Infosys reported $5.145B revenue, with AI revenue up 29%. Kotak Mahindra Bank's profit rose 29% YoY. Dr. Reddy's revenue declined 1.5% YoY. FOMC meets Oct. 27-28.

Original reporting
Published Oct 26, 2026, 4:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 5:06 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Hindustan Times Reports India’s Benchmarks Open Lower as Oil Eases — source image
Decision brief

The 30-second read

$INFYNeutralMed
01

Why it matters

Earnings releases provide new data points for pricing Indian ADRs and influence sector sentiment in the near term.

02

Market read

Fresh earnings data for three Indian ADRs could drive short‑term price moves; oil easing may provide broader market support.

03

What to watch

Kotak's profit surge could be driven by one‑off items; Dr. Reddy’s may have pipeline catalysts later in the year.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

The article summarizes early‑morning Indian market moves as oil prices ease, and reports fresh quarterly results for three major Indian companies.

Company-level read

Ticker impact

$INFYNeutralHigh confidence
Context

Infosys posted Q3 revenue of $5.145 bn, modest growth and FY27 outlook of 1‑2% revenue growth.

Expected impact

likely pressure as the market prices in the low‑growth guidance

Evidence & confidence

Revenue grew only 1.5% YoY and guidance is flat, which is below expectations for a tech leader.

Market effects

Tech services earnings may temper broader Indian IT sector sentiment; banking strength supports financials; pharma slowdown could pressure healthcare stocks.

Positive for Indian banking index, neutral to negative for Indian IT and pharma indices.

Limited; primarily affects investors with exposure to Indian ADRs and emerging‑market equities.

Counterpoint

Despite modest growth, Infosys may benefit from AI spend acceleration not reflected in guidance.

Key entities

  • Infosys

    Indian IT services firm

  • Kotak Mahindra Bank

    Indian banking institution

  • Dr. Reddy’s Laboratories

    Indian pharmaceutical company

Related articles

$INFYHighAI 8/10

Infosys shares fall 4% after FY27 revenue growth guidance cut

Infosys shares dropped 4% after cutting FY27 revenue growth guidance to 1-2% from 1.5-3% due to sluggish client spending. Q2 revenue was ₹49,244 crore, up 1.5% y-o-y, with net profit increasing 6.2%. Goldman Sachs and Citi noted subdued demand and maintained neutral ratings with target prices of ₹1,000 and ₹1,105, respectively.

$INFYHighAI 8/10

Why is Infosys stock falling today?

Infosys (INFY) shares fell 1.5% after lowering its full-year revenue growth forecast to 1%–2% from 1.5%–3%, citing slower project volumes and pricing pressure. UBS cut its price target to ₹1,415 from ₹1,430, maintaining a Buy rating. Q2 revenue growth and EBIT margin missed expectations.

$INFYMed

Buy Infosys; target of Rs 1300: Emkay Global Financial

Infosys reported weak 2Q results, missing revenue and margin estimates. Revenue grew 1.2% CC, while EBITM declined 10bps. The company revised its FY27 revenue growth guidance down to 1-2% CC. Emkay Global Financial maintains a 'Buy' rating with a target price of Rs 1300, citing AI growth and large deals.